ConsulTech Logo

Horizon Europe: planned health calls for 2023/24

There is a pre-publication for project topics in cluster 1 (health) for which applications can be submitted in 2023 and 2024.
Of course, it can be assumed that there will be changes, because the discussion about the details is in full progress.
Nevertheless, the headings provide insights into the current state of affairs and indicate whether one or the other may prepare for an application.
Contact us if you are interested in the call text.

Destination 1. Staying healthy in a rapidly changing society

HORIZON-HLTH-2023-STAYHLTH-1.01: The Silver Deal - Person-centred health and care throughout the EU
HORIZON-HLTH-2023-STAYHLTH-1.02: Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society
HORIZON-HLTH-2023-STAYHLTH- 1.04: Improving population level screening strategies and programmes for non-communicable diseases
HORIZON-HLTH-2024-STAYHLTH- 1.05: Personalised prevention for non- communicable diseases - addressing areas of unmet needs using multiple data sources
Destination 2. Living and working in a health-promoting environment
HORIZON-HLTH-2023-ENVHLTH- 2.01: Planetary health: understanding the links between environmental degradation and health impacts
HORIZON-HLTH-2023-ENVHLTH- 2.02: Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces)
HORIZON-HLTH-2023-ENVHLTH- 2.03: Research in support of identification and understanding of human health effects of endocrine disrupting chemicals
HORIZON-HLTH-2023-ENVHLTH- 2.04: Global coordination of exposome research
HORIZON-HLTH-2024-ENVHLTH- 2.05: Exposure to hazardous substances (including nanomaterials) or biological agents in occupational environments and adverse health outcomes
HORIZON-HLTH-2024-ENVHLTH- 2.06: The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution

Destination 3. Tackling diseases and reducing disease burden
HORIZON-HLTH-2023-DISEASE- 3.01: Palliative and end-of-life care for non-cancer patients
HORIZON-HLTH-2023-DISEASE- 3.03: Interventions in urban environments to reduce NCD risk (GACD)
HORIZON-HLTH-2023-DISEASE- 3.04: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential (Pandemic preparedness research)
HORIZON-HLTH-2023-DISEASE- 3.05: Sustaining European Clinical Trial networks for pandemic preparedness and response through well-established coordination mechanisms between EU adaptive platform trials (CSA for pandemic preparedness research)
HORIZON-HLTH-2023-DISEASE- 3.06: Towards a European partnership on brain health
HORIZON-HLTH-2023-DISEASE- 3.07: Relationship between infectious and non- communicable diseases (Comorbidities - relationship between infectious pathogens and non-communicable diseases and its relevance to comorbidities)
HORIZON-HLTH-2024-DISEASE- 3.08: Comparative effectiveness research for healthcare interventions in areas of high public health need
HORIZON-HLTH-2024-DISEASE- 3.09: Contribution to the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R) coordinated funding initiative (co-programmed preparedness research at international level)
HORIZON-HLTH-2024-DISEASE- 3.10: Integrated management of multimorbidity (GACD)
HORIZON-HLTH-2024-DISEASE- 3.11: Adaptive platform trials for pandemic preparedness (Pandemic preparedness research)
HORIZON-HLTH-2024-DISEASE- 3.12: Maintaining the European partnership for pandemic preparedness (CSA for Pandemic preparedness research)
HORIZON-HLTH-2024-DISEASE- 3.13: Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
HORIZON-HLTH-2024-DISEASE-3.14: Tackling under-researched high-burden medical conditions
HORIZON-HLTH-2023-DISEASE- P5: European Partnership on Rare Diseases
HORIZON-HLTH-2024-DISEASE- P6: European Partnership: One Health Anti- Microbial Resistance

HERA-specific topics
Destination 4. Ensuring access to innovative, sustainable and high-quality health care

HORIZON-HLTH-2023-CARE- 4.1: Maintaining access to regular care in case of cross-border health emergencies
HORIZON-HLTH-2023-CARE- 4.2: A resilient health and care workforce for the future
HORIZON-HLTH-2023-CARE- 4.3: Environmentally sustainable and decarbonised health and care systems
HORIZON-HLTH-2024-CARE- 4.4: Access to health and care services for vulnerable groups
HORIZON-HLTH-2024-CARE- 4.5: Pre-commercial procurement for environmentally sustainable and low-carbon health and care systems
HORIZON-HLTH-2023-CARE- P4: European Partnership on Personalised Medicine

Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
HORIZON-HLTH-2023-TOOL- 5.01: Clinical trials of Combined ATMPs
HORIZON-HLTH-2023-TOOL- 5.03: Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management
HORIZON-HLTH-2023-TOOL- 5.04: Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes, research and innovation
HORIZON-HLTH-2023-TOOL- 5.05: Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery
HORIZON-HLTH-2024-TOOL- 5.02: Bio-printing of living cells for regenerative medicine
HORIZON-HLTH-2024-TOOL-5.06: Innovative non-animal human-based tools and strategies for biomedical research
HORIZON-HLTH-2023-IND- 6.01: Supporting the uptake of innovative HTA methodology and advancing HTA expertise across EU
HORIZON-HLTH-2023-IND- 6.02: Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space
HORIZON-HLTH-2023-IND- 6.03: Setting up a European wide collaborative mechanism to support the adoption of innovative health solutions across European regions
HORIZON-HLTH-2023-IND- 6.04: Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines
HORIZON-HLTH-2023-IND- 6.05: Mapping of regulatory requirements for the translation of Advanced Therapy Medicinal Products (ATMP)
HORIZON-HLTH-2023-IND- 6.06: Innovation Partnership 2024 – Development procurement and responsible management of new antimicrobials
HORIZON-HLTH-2024-IND- 6.07: Development and harmonisation of methodologies for assessing digital health technologies in Europe
HORIZON-HLTH-2024-IND- 6.08: Developing an EU methodological framework for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)